Argentum Medical is founded to manufacture Silverlon Antimicrobial Dressings
First Silverlon® sale to U.S. Department of Defense
BioDerm launches full scale, national direct-to-consumer sales campaign
BioDerm introduces three new adjunct product lines:
Cura Surgical, led by Raul Brizuela, acquires Argentum Medical
BioDerm establishes distribution agreements in Canada and the Middle East
Argentum acquires TheraBond 3D®, enhancing its presence in the burn care market
BioDerm partners with Medline to launch Men’s LibertyTM Acute in the USA & Canada
BioDerm completes acquisition of Wound Care ResourcesTM, Inc., a DME specializing in providing wound care supplies to VAD patients nationally
Silverlon® receives 510k clearance of Burn and Wound Care Products for Vapor Sulfur Mustard Indication
Argentum enters circulatory support market, and partners with MedTech Solutions Group to expand global footprint
Argentum acquires Anacapa Technologies (Anasept® and Silver-Sept®)
Silverlon® receives FDA Breakthrough Device Designation for use in Radiation Dermatitis and Cutaneous Radiation Injury
2nd FDA Clearence: Management of CRIs through dry desquamation
Argentum merges with BioDerm
Argentum and BioDerm rebrand as Bravida Medical and establishes a first international facility to grow Middle East business
3rd FDA Clearence: Management of acute CRIs through moist desquamation
